Literature DB >> 9087816

Quantification of hemodialysis: analysis of methods and the relevance to patient outcome.

W R Clark1, M V Rocco, A J Collins.   

Abstract

Quantification of small solute removal in patients treated with chronic hemodialysis (HD) is widely used to assessed the adequacy of both prescribed and delivered treatment. Four recent American studies have demonstrated a clear relationship between delivered dialysis dose and outcome in chronic HD patients. Although a number of HD quantification methods have been proposed, no specific technique is accepted as the gold standard at present. The primary goal of this review is to provide a critical assessment of the four recently published studies relating to HD outcome to dialysis dose. As these studies involved a variety of therapy quantification methods, a review of the most common techniques used to measure dialysis dose is also presented. In addition, two unresolved issues that have recently come to the forefront of HD quantification are presented. These issues are the role of dialysate-side measurement of HD dose and the potential limit of the beneficial effect of increasing HD dose on clinical outcome. Finally, the overall design of the NIH HD adequacy trial is discussed, with particular attention paid to the kinetic methods used in the study.

Entities:  

Mesh:

Year:  1997        PMID: 9087816     DOI: 10.1159/000170321

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  3 in total

1.  Polyneuropathy in hemodialysis patients: the most sensitive electrophysiological parameters and dialysis adequacy.

Authors:  Tanja Hojs-Fabjan; Radovan Hojs
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

2.  Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis.

Authors:  L R Narasimhan; W Goodman; C K Patel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 3.  Dialysis dose in acute kidney injury: no time for therapeutic nihilism--a critical appraisal of the Acute Renal Failure Trial Network study.

Authors:  Claudio Ronco; Dinna Cruz; Helen Oudemans van Straaten; Patrick Honore; Andrew House; Du Bin; Noel Gibney
Journal:  Crit Care       Date:  2008-10-16       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.